Drug
Trastuzumab Deruxtecan
Data on this page refer exclusively to patients treated with
Trastuzumab Deruxtecan combined with SBRT, without concurrent use of
drugs from other classes.
Combination therapy data and pooled group-level evidence are available on the
ADC group page.
Drug Profile
| Therapeutic Class | Antibody-Drug Conjugates (ADCs) |
| Drug Class | — |
| Group | ADC |
| Mechanism of Action | HER2 targeting ADC |
| Half-life | 7 d |
